Literature DB >> 23314917

Matrix metalloproteinase-14 is a negative prognostic marker for patients with gastric cancer.

Liang He1, Dake Chu, Xia Li, Jianyong Zheng, Shanhong Liu, Jipeng Li, Qingchuan Zhao, Gang Ji.   

Abstract

BACKGROUND: Matrix metalloproteinase-14 (MMP-14) has been considered to play an important role in invasion and metastasis of human solid tumor. AIM: The present study aimed to investigate the association of MMP-14 with overall survival in human gastric cancer.
METHODS: Gastric cancer and adjacent normal specimens were collected from 205 patients who had not received neoadjuvant chemotherapy. MMP-14 expression was investigated by immunohistochemistry assay and staining evaluation results were analyzed statistically in relation to overall survival of patients.
RESULTS: MMP-14 expression proved to be increased in gastric cancer compared with that in normal tissues. It was also proved that MMP-14 expression was associated with tumor invasion, metastasis, and TNM stage while no correlations were detected between MMP-14 expression and age, sex, differentiation status, or Lauren's classification. Moreover, patients with gastric cancer of MMP-14-positive expression tend to have worse overall survival compared with those with MMP-14 negative expression.
CONCLUSIONS: The present study confirmed the over-expression of MMP-14 in human gastric cancer and its association with tumor progression. It also provided the first evidence that MMP-14 expression in gastric cancer was an independent negative prognostic factor of patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23314917     DOI: 10.1007/s10620-012-2513-9

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  35 in total

Review 1.  Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis.

Authors:  S Curran; G I Murray
Journal:  Eur J Cancer       Date:  2000-08       Impact factor: 9.162

2.  Antibody microarray-based technology to rapidly define matrix metalloproteinase (MMP) signatures in patients undergoing resection for primary gastric carcinoma.

Authors:  Manuel Puig-Costa; Cristina Oliveras-Ferraros; Silvia Flaquer; Francesca Llopis-Puigmarti; Eulalia Pujol-Amado; Begoña Martin-Castillo; Alejandro Vazquez-Martin; Sílvia Cufí; Rosa Ortiz; Josep Roig; Antonio Codina-Cazador; Javier A Menendez
Journal:  J Surg Oncol       Date:  2011-02-09       Impact factor: 3.454

Review 3.  Matrix metalloproteinases in tumour invasion and metastasis.

Authors:  S Curran; G I Murray
Journal:  J Pathol       Date:  1999-11       Impact factor: 7.996

4.  MT1-MMP cooperates with Kras(G12D) to promote pancreatic fibrosis through increased TGF-β signaling.

Authors:  Seth B Krantz; Mario A Shields; Surabhi Dangi-Garimella; Eric C Cheon; Morgan R Barron; Rosa F Hwang; M Sambasiva Rao; Paul J Grippo; David J Bentrem; Hidayatullah G Munshi
Journal:  Mol Cancer Res       Date:  2011-08-19       Impact factor: 5.852

5.  Effects of the combination of hyperbaric oxygen and 5-fluorouracil on proliferation and metastasis of human nasopharyngeal carcinoma CNE-2Z cells.

Authors:  Zheng-Rong Peng; Wei-Hong Zhong; Juan Liu; Ping-Tian Xiao
Journal:  Undersea Hyperb Med       Date:  2010 May-Jun       Impact factor: 0.698

Review 6.  Incidence and mortality of gastric cancer in China.

Authors:  Ling Yang
Journal:  World J Gastroenterol       Date:  2006-01-07       Impact factor: 5.742

7.  Matrix metalloproteinase-9 is associated with disease-free survival and overall survival in patients with gastric cancer.

Authors:  Dake Chu; Zixi Zhang; Yunming Li; Jianyong Zheng; Guanglong Dong; Weizhong Wang; Gang Ji
Journal:  Int J Cancer       Date:  2010-12-08       Impact factor: 7.396

8.  Matrix metalloproteinases and their inhibitors in gastric cancer.

Authors:  G I Murray; M E Duncan; E Arbuckle; W T Melvin; J E Fothergill
Journal:  Gut       Date:  1998-12       Impact factor: 23.059

9.  The influence of MMP-14, TIMP-2 and MMP-2 expression on breast cancer prognosis.

Authors:  Bernard Têtu; Jacques Brisson; Chang Shu Wang; Hélène Lapointe; Geneviève Beaudry; Caty Blanchette; Dominique Trudel
Journal:  Breast Cancer Res       Date:  2006-06-15       Impact factor: 6.466

10.  Global gene expression profiling of human pleural mesotheliomas: identification of matrix metalloproteinase 14 (MMP-14) as potential tumour target.

Authors:  Stefania Crispi; Raffaele A Calogero; Mario Santini; Pasquale Mellone; Bruno Vincenzi; Gennaro Citro; Giovanni Vicidomini; Silvia Fasano; Rosaria Meccariello; Gilda Cobellis; Simona Menegozzo; Riccardo Pierantoni; Francesco Facciolo; Alfonso Baldi; Massimo Menegozzo
Journal:  PLoS One       Date:  2009-09-15       Impact factor: 3.240

View more
  21 in total

1.  A role of MMP-14 in the regulation of invasiveness of nasopharyngeal carcinoma.

Authors:  Jian Zhao; Zhongyu Kong; Feng Xu; Wei Shen
Journal:  Tumour Biol       Date:  2015-06-04

2.  MMP14 regulates cell migration and invasion through epithelial-mesenchymal transition in nasopharyngeal carcinoma.

Authors:  Tinghua Yan; Zhonghao Lin; Jinhua Jiang; Suiwan Lu; Miaoan Chen; Huaxing Que; Xiangsheng He; Ganbo Que; Jianfeng Mao; Jinan Xiao; Qingwei Zheng
Journal:  Am J Transl Res       Date:  2015-05-15       Impact factor: 4.060

3.  Increased MT2-MMP expression in gastric cancer patients is associated with poor prognosis.

Authors:  Xiaoli Xu; Lujun Chen; Bin Xu; Quanqin Xie; Mingfen Sun; Xu Deng; Changping Wu; Jingting Jiang
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

4.  Decreased MT1-MMP in gastric cancer suppressed cell migration and invasion via regulating MMPs and EMT.

Authors:  Wenfeng Li; Shouzhi Li; Liang Deng; Shibin Yang; Mingzhe Li; Shuo Long; Sile Chen; Fuxiang Lin; Longbin Xiao
Journal:  Tumour Biol       Date:  2015-04-08

Review 5.  Inflammation-related factors predicting prognosis of gastric cancer.

Authors:  Wen-Jun Chang; Yan Du; Xin Zhao; Li-Ye Ma; Guang-Wen Cao
Journal:  World J Gastroenterol       Date:  2014-04-28       Impact factor: 5.742

6.  Quantitative mapping of binding specificity landscapes for homologous targets by using a high-throughput method.

Authors:  Lidan Aharon; Shay-Lee Aharoni; Evette S Radisky; Niv Papo
Journal:  Biochem J       Date:  2020-05-15       Impact factor: 3.857

Review 7.  New advances in targeted gastric cancer treatment.

Authors:  Daniela Cornelia Lazăr; Sorina Tăban; Marioara Cornianu; Alexandra Faur; Adrian Goldiş
Journal:  World J Gastroenterol       Date:  2016-08-14       Impact factor: 5.742

8.  Immunoexpression of metalloproteinases 2 and 14 and TIMP-2 inhibitor in main types of primary gastric carcinomas and lymph node metastasis.

Authors:  Daniel Cordeiro Gurgel; José Telmo Valença-Junior; Conceição Aparecida Dornelas; Renato Braga Vieira; João Tarcisio Alves Maia-Filho; Roberto Cesar Pereira Lima-Junior; Ronaldo Albuquerque Ribeiro; Paulo Roberto Carvalho Almeida
Journal:  Pathol Oncol Res       Date:  2014-05-07       Impact factor: 3.201

9.  The overexpression membrane type 1 matrix metalloproteinase is associated with the progression and prognosis in breast cancer.

Authors:  Yongping Li; Guohong Cai; Shifang Yuan; Yi Jun; Nanlin Li; Ling Wang; Feng Chen; Rui Ling; Jun Yun
Journal:  Am J Transl Res       Date:  2015-01-15       Impact factor: 4.060

10.  MT1-MMP is not a good prognosticator of cancer survival: evidence from 11 studies.

Authors:  Kun-Peng Wu; Qiang Li; Fu-Xiang Lin; Jun Li; Lu-Min Wu; Wei Li; Qiao-Zhu Yang
Journal:  Tumour Biol       Date:  2014-09-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.